Yilmaz Mehmet Birhan, Laribi Said, Mebazaa Alexandre
Cumhuriyet University School of Medicine, Sivas, Turkey.
Curr Heart Fail Rep. 2010 Sep;7(3):110-5. doi: 10.1007/s11897-010-0014-8.
The role of beta-blockers in heart failure has been long debated. Data from chronic heart failure studies clearly indicate that beta-blockers save lives. However, data concerning use of beta-blockers in patients with acute heart failure are limited, and only recently have emerged to help guide therapy. In this review, we provide an overview of when to stop and when to start beta-blockers in patients with acute heart failure.
β受体阻滞剂在心力衰竭中的作用长期以来一直存在争议。慢性心力衰竭研究的数据清楚地表明,β受体阻滞剂能挽救生命。然而,关于β受体阻滞剂在急性心力衰竭患者中应用的数据有限,直到最近才出现以帮助指导治疗。在这篇综述中,我们概述了急性心力衰竭患者何时停用以及何时开始使用β受体阻滞剂。